Antiarrhythmic and cardiohemodynamic effects of a novel Ca 2+ channel blocker, AH-1058, assessed in canine arrhythmia models

By Takahara A.   Sugiyama A.   Dohmoto H.   Yoshimoto R.   Hashimoto K.  

European Journal of Pharmacology, Vol. 398, Iss. 1, 2000-06 ,pp. : 107-112

Elsevier

Access to resources Recommend Favorite

Effects of a dual L/N-type Ca 2+ channel blocker cilnidipine on neurally mediated chronotropic response in anesthetized dogs

By Konda T.   Takahara A.   Maeda K.   Dohmoto H.   Yoshimoto R.  

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 117-120

Elsevier

Access to resources Recommend Favorite

Hemodynamic effects of MF 10058, a new cardioselective muscarinic M 2 receptor antagonist, in conscious dogs

By Lamperti G.   Champeroux P.   Martel E.   Colibretti M.L.   Santoro L.   Imbimbo B.P.  

European Journal of Pharmacology, Vol. 406, Iss. 1, 2000-10 ,pp. : 93-98

Elsevier

Access to resources Recommend Favorite

Effect of the Cardioselective, Sarcolemmal K_ATP Channel Blocker HMR 1098 on Atrial Electrical Remodeling During Pacing-Induced Atrial Fibrillation in Dogs

By Vereckei András   Gögelein Heinz   Wirth Klaus   Zipes Douglas  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 23-30

Springer Publishing Company

Access to resources Recommend Favorite

Forskolin's structural analogue 1,9-dideoxyforskolin has Ca 2+ channel blocker-like action in rat cerebellar granule cells

By Zerr P.   Becherer U.   Rodeau J.-L.   Feltz A.  

European Journal of Pharmacology, Vol. 303, Iss. 1, 1996-05 ,pp. : 101-108

Elsevier

Access to resources Recommend Favorite